improving treatment access with off-the-shelf bispecific antibodies in multiple myeloma
Published 3 months ago • 52 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
3:07
developing guidelines for the management of infections following treatment with bispecifics
-
1:42
how to best sequence bispecific antibodies and car-t therapy in multiple myeloma
-
1:45
using the available repertoire of bispecific antibodies for treating multiple myeloma
-
2:12
risk of infection and mitigation strategies in patients with myeloma treated with bispecifics
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
19:39
t-cell engagers: targets, challenges and opportunity
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
11:01
how disease biology can influence treatment decisions (impact audio lessons)
-
1:22
risk of infection in patients with multiple myeloma treated with bispecific antibodies
-
3:02
optimal treatment strategies for multiple myeloma
-
1:01
considerations to optimize the outcomes of bispecific antibody treatment in patients with myeloma
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
6:17
myeloma made simple: bispecific antibodies made simple | bispecific antibodies for myeloma treatment
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
1:06
feasibility of treatment with bispecifics in patients with myeloma with prior bcma exposure
-
2:26
emerging immunotherapeutic strategies for multiple myeloma in the frontline and r/r settings
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
1:44
optimal treatment sequencing in multiple myeloma
-
1:41
innovative treatment strategies for multiple myeloma
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:52
how is bispecific antibody therapy changing myeloma care?
-
3:10
immunotherapy for the treatment of multiple myeloma